Chart
Continuous Bioprocessing Market to Reach $2.3B by 2035, Driven by Biosimilar Pressure and Mega-Site Investment
A once-niche manufacturing technology is going mainstream, as biopharma’s biggest players bet billions on replacing batch production with “always-on” continuous bioprocessing. According to Astute Analytica’s 2026 market report, the continuous bioprocessing market was valued at $319.77 million in 2025 and
17 February 2026
